Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Timolol hemihydrate vs timolol maleate to treat ocular hypertension and open-angle glaucoma.
DuBiner HB, Hill R, Kaufman H, Keates EU, Zimmerman TJ, Mandell AI, Mundorf TK, Bahr RL, Schwartz LW, Towey AW, Hurvitz LM, Starita RJ, Sassani JW, Ropo A, Gunn R, Stewart WC. DuBiner HB, et al. Among authors: mundorf tk. Am J Ophthalmol. 1996 May;121(5):522-8. doi: 10.1016/s0002-9394(14)75426-1. Am J Ophthalmol. 1996. PMID: 8610795 Clinical Trial.
Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S, Mundorf TK, Stewart JA, Stewart WC. Sonty S, et al. Among authors: mundorf tk. Clin Ther. 2009 Oct;31(10):2063-71. doi: 10.1016/j.clinthera.2009.10.003. Clin Ther. 2009. PMID: 19922877 Clinical Trial.
34 results